| XBRANE BIOPHARMA AB |
| Schweden |
| Gesundheit |
| SE0026598583 / A41PJJ |
| 7XB0 (Frankfurt) |
| FRA:7XB0, ETR:7XB0, 7XB0:GR |
| - |
| https://www.xbrane.com/ |
|
Xbrane Biopharma AB is a Sweden-based biotechnology company specializing in the development, manufacture, and commercialization of biosimilars. These follow-on biologics target high-cost originator drugs, aiming to provide affordable alternatives for..
>Volltext.. |
| 13 Mio. EUR |
| 10.45 Mio. EUR |
| 14.12 Mio. EUR |
| -1.53 Mio. EUR |
| 11.79 Mio. EUR |
| 0.58 EUR |
| 5.4 Mio. EUR |
| 8.02 Mio. EUR |
| -23.23 Mio. EUR |
| 1.64 |
| -23.33% |
| - |
| - |
| - |
| - |
| - |
| XBRANE |
| 08.04.26 |
|